Thus, it is speculated that the high malignancy of leukemic cells in AML cases with complex abnormal karyotype and MYC amplification is attributed not only to MYC amplification but also to additional activation of other oncogenes and loss of tumor suppressor genes [6]. Here, MYC is linked to acute myeloid leukemia.